Comparative simulation of pneumococcal serogroup 19 polysaccharide repeating units with two carbohydrate force fields

Michelle Kuttel1, Marc Gordon1, Neil Ravenscroft2

  • 1Department of Computer Science, University of Cape Town, Cape Town, South Africa.

Carbohydrate Research
|April 1, 2014
PubMed

Insights

Pneumococcal conjugate vaccine PCV7 shows low effectiveness against the 19A serotype. Molecular dynamics simulations reveal distinct conformational differences between 19F and 19A polysaccharides, explaining the limited cross-protection observed in infant immunisation programs.

Area of Science:

  • Microbiology
  • Immunology
  • Computational Chemistry

Background:

  • Streptococcus pneumoniae causes invasive pneumococcal disease (IPD) in children.
  • PCV7 vaccine reduced IPD, but non-vaccine serotypes like 19A have increased.
  • PCV7 shows only 26% effectiveness against 19A IPD, despite 19F presence in the vaccine.

Purpose of the Study:

  • To investigate the conformational and dynamic differences between 19F and 19A pneumococcal polysaccharide repeating units.
  • To understand the molecular basis for the low cross-protection of PCV7 against 19A serotype infections.

Main Methods:

  • 100ns aqueous molecular dynamics simulations of di- and trisaccharide components.
  • Comparison of free energy surfaces for glycosidic linkages.
  • Utilized both CHARMM and GLYCAM carbohydrate force fields for calculations.

Main Results:

  • Both CHARMM and GLYCAM force fields predicted distinct conformational behaviors for 19F and 19A polysaccharides.
  • The 19F repeating unit exhibited a wider range of conformation families compared to the more restricted 19A trisaccharide.
  • Key differences were identified between the force fields, but overall trends were consistent.

Conclusions:

  • A probable conformational difference exists between 19F and 19A polysaccharides.
  • This conformational disparity likely explains the limited cross-protection of PCV7 vaccines against 19A invasive pneumococcal disease.